CGT Global Blog
CGT Global News
Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.
Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply
1. Leukopaks (RUO, Mobilized, Clinical, and GMP Aligned) Leukopaks remain one of the most common upstream inputs for immune cell workflows. We support formats that match how cell therapy teams actually operate. RUO leukopaks Fresh and cryopreserved options for discovery, preclinical, and process development. Mobilized leukopaks Mobilized options for programs requiring higher progenitor content or mobilized immune starting material. Clinical and GMP aligned leukopakshttps://cgt.global/human-blood-products/mobilized-peripheral-blood/mobilized-peripheral-blood-leukopaks/ Fresh and cryopreserved clinical grade options designed for teams moving toward trials and manufacturing scale. If you are…
Cryopreserved Leukopak Viability and Supplier Selection
What to Expect Post Thaw and How to Choose a GMP Partner Cryopreserved leukopaks are getting adopted fast for one simple reason. Fresh starting material creates supply chain risk. Leukopak deliveries can be late, arrive outside temperature requirements, or miss a critical manufacturing window entirely. When that happens, teams do not just lose a leukopak. They lose staff time, reagents, a manufacturing slot, and sometimes patient scheduling flexibility. Cryopreservation is one of the most practical ways to remove many of those failure…
GMP Leukopak Partner Guide for Clinical Development
Plus a Fresh vs Cryopreserved Decision Guide for Allogeneic Programs If you are building a cell therapy program, your starting material is not a minor detail. It is one of the biggest drivers of downstream consistency, cost, and timeline risk. That is why the GMP leukopak has become a cornerstone input for teams moving from discovery into clinical development. In plain terms, a GMP leukopak is a concentrated collection of white blood cells that is collected, handled, tested, and documented under Good…
Advancing CAR NK Therapy: Why Leukopak Quality and Donor Characterization Matter
CAR NK therapy is gaining traction as a next wave cell therapy platform. Compared to CAR T, CAR NK programs offer the potential for allogeneic manufacturing, improved safety profiles, and scalable off the shelf products. But CAR NK workflows are less forgiving when it comes to starting material. NK cells are more sensitive to collection conditions, handling, and donor variability. That makes leukopak quality and donor characterization critical inputs for consistent NK cell isolation and expansion. If those inputs are not controlled,…
Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing
Why the fresh vs cryo decision matters Most CAR T processes are built around predictable inputs. When those inputs shift, it becomes harder to hit target yields, expansion timing, and manufacturing release criteria. Fresh and cryopreserved leukopaks differ in: logistics and scheduling flexibility post processing recovery and expansion behavior sensitivity to handling variables lot to lot consistency Choosing the right format is not about “which is better.” It is about what your process and program stage require. Fresh leukopaks Best for workflows…
Armored CAR T
Strengthening T Cells for the Toughest Tumors CAR T therapy changed what is possible in blood cancers. But solid tumors remain one of the toughest frontiers in oncology. Not because we do not know what to target.Because the tumor environment fights back. Solid tumors suppress immune activity, block infiltration, and exhaust T cells before they can finish the job. That is why the next chapter of CAR T is not only about recognition. It is about survival, persistence, and control inside hostile…
Best CD34+ Cell Suppliers for 2026: Comparing Bone Marrow, Cord Blood, and Mobilized Sources
Introduction CD34+ hematopoietic stem and progenitor cells are critical to cell therapy development, gene editing workflows, and translational immunology research. Whether sourced from bone marrow, mobilized peripheral blood, or cord blood, CD34 cell quality and documentation directly influence downstream expansion, differentiation, and functional outcomes. In 2026, research teams are evaluating suppliers based not only on availability, but also on donor screening transparency, isolation methodology, documentation standards, and logistical reliability. This comparison reviews leading CD34 cell suppliers serving academic, biotech, and translational research…
Best Mobilized Leukopak Suppliers for 2026: G-CSF vs. Plerixafor Compared
Introduction Mobilized leukopaks are essential starting material for advanced cell therapies, immune research, and manufacturing optimization. By mobilizing hematopoietic stem and progenitor cells (HSPCs) from the bone marrow into the bloodstream using agents like G-CSF or plerixafor, researchers can isolate higher yields of CD34+ and target immune cells for CAR T, NK, and other immunotherapy platforms. To understand how mobilization enhances yield and performance, see our detailed guide on Mobilized Leukopaks for Research. As demand for high-yield, donor-characterized, and recallable leukopaks grows,…
Optimizing PBMC Viability and Recovery: Updated Best Practices for 2026
In biomedical research, the viability and recovery of peripheral blood mononuclear cells (PBMCs) determine the reliability of downstream results. Over the past few years, advances in donor screening, cryopreservation, and logistics have dramatically improved the consistency of primary immune cell performance. Yet, small variables—temperature shifts, prolonged DMSO exposure, or donor differences—still account for major discrepancies in experimental reproducibility. At CGT Global, we continuously evaluate the factors that most influence PBMC quality to help researchers obtain high-viability, high-recovery results from every sample. This…
Meet CGT Global’s Scientific Team: Sophia Johnson Associate Director of Logistic Operations
For cell procurement and delivery operations to run smoothly, countless moving parts must align. From understanding the needs of a research project to scheduling donors, fulfilling orders, and ensuring precise delivery, every step must fit together seamlessly. So, who keeps everything ticking like a perfectly timed clock? Meet Sophia Johnson, Associate Director of Logistic Operations at CGT Global. Sophia has been with CGT Global for 6 years, bringing her background in psychology and a talent making the puzzle pieces fit applying her expert planning and organization skills. While at Sonoma State, Sophia…
Scaling Humanized Immune System Mouse Models: Optimize Your CD34+ Engraftment with High Quality Cells
Table of contents Key Takeaways CD34+ humanized mice enable better predictions for therapies, reducing the translational gap between humans and mice. High-quality CD34+ cells from CGT Global enhance engraftment success rates for HIS mice in preclinical studies. Cell viability, purity, and accurate counts are crucial for consistent and predictive data from these models. Ordering bulk CD34+ cells can significantly reduce costs and improve experimental workflows for researchers. CGT Global offers customized solutions and resources to support scientists in their CD34+ cell sourcing…
Top PBMC Suppliers for 2026: Fresh, Cryopreserved, and GMP-Grade Options Compared
Introduction Peripheral Blood Mononuclear Cells (PBMCs) are foundational to immunology, oncology, and cell therapy research. Whether they are used for functional assays, vaccine development, or discovery-stage therapeutic studies, PBMC quality directly impacts data accuracy and reproducibility. In 2026, researchers expect more than just availability. They look for documented donor screening, consistent viability, and responsive support. This comparison reviews the top PBMC suppliers serving academic, biotech, and translational research programs, focusing on quality, logistics, and communication. Disclosure: This comparison was developed by CGT…